Sorafenib for patients with differentiated thyroid cancer--authors' reply.
Publication/Presentation Date
1-17-2015
Volume
385
Issue
9964
First Page
228
Last Page
229
ISSN
1474-547X
Published In/Presented At
Brose, M. S., Schlumberger, M., Peña, C., & Kappeler, C. (2015). Sorafenib for patients with differentiated thyroid cancer--authors' reply. Lancet (London, England), 385(9964), 228–229. https://doi.org/10.1016/S0140-6736(15)60056-3
Disciplines
Medicine and Health Sciences
PubMedID
25706706
Department(s)
Hematology-Medical Oncology Division
Document Type
Article
COinS